Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A by Wallace-Gadsden, Faith et al.
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 5, May 2007  757 
Enteroaggregative 
Escherichia coli 
Related to 
Uropathogenic 
Clonal Group A 
Faith Wallace-Gadsden,*1 James R. Johnson,†‡ 
John Wain,§ and Iruka N. Okeke*
Enteroaggregative  Escherichia coli (EAEC) are het-
erogeneous, diarrheagenic E. coli. Of EAEC strains from 
Nigeria, 10 independent antimicrobial-resistant isolates be-
longed to the multilocus sequence type 69 clonal complex, 
to which uropathogenic E. coli clonal group A belongs. This 
ﬁ  nding suggests a recent common ancestor for these dis-
tinct groups of pathogenic E. coli.
E
nteroaggregative Escherichia coli (EAEC) is an emerg-
ing category of diarrheagenic E. coli. EAEC are het-
erogeneous, and the distribution of known virulence genes 
rarely correlates with phylogeny based on housekeeping 
loci (1). We recently identiﬁ  ed 2 loci, involved in iron ac-
quisition, that are distributed among EAEC in a manner 
that correlates with multilocus enzyme electrophoresis typ-
ing based on 20 housekeeping enzymes (2). This ﬁ  nding 
supports the possibility that EAEC clonal groups with in-
creased pathogenic potential exist. 
The Study
To identify overrepresented subgroups of potential 
clonal origin, we examined 131 EAEC strains isolated from 
children in Nigeria (3), 73 from 187 children with diarrhea 
and 58 from 144 healthy control participants. All 131 strains 
had previously been categorized as EAEC by the standard 
HEp-2 cell adherence assay (3,4). To determine ﬂ  agellin 
types, we used an RsaI-based PCR–restriction fragment 
length polymorphism (RFLP) protocol. Using primers F-
FLIC1 (5′-ATGGCACAAGTCATTAATACCCAAC-3′) 
and R-FLIC2 (5′-CTAACCCTGCAGCAGAGACA-3′), 
we obtained an internal ﬂ  iC amplicon from 105 (80.1%) 
of the 131 isolates. RFLP analysis delineated >31 ﬂ  agellin 
genotypes among these amplicons (online Appendix Table, 
available at www.cdc.gov/EID/content/13/5/757-appT.
htm). Using 16 control strains, which represented 12 anti-
genically distinct H-types veriﬁ  ed at reference centers, we 
could associate a speciﬁ  c H antigen with 10 of these RFLP 
patterns. The most common pattern, which corresponded 
with the H18 antigen, accounted for 18 (17%) of the gen-
otyped isolates (or 14% of all isolates). Two H7 control 
strains had different genotypes, which indicates that the 
products of 2 different alleles are recognized by anti-H7 
antiserum. Both genotypes were detected among the test 
EAEC strains (online Appendix Table) and together ac-
counted for 10 (7.6%) of the isolates. Other predominant 
ﬂ  iC variants were H2 (3%), H11 (3.8%), H21 (7.6%), and 
H45 (4.9%). Although some ﬂ  iC variants were somewhat 
more common among strains from children with diarrhea 
than from control participants (online Appendix Table), 
differences were not statistically signiﬁ  cant (p>0.05, Fisher 
exact test).
Antimicrobial susceptibility proﬁ  les were determined 
by disk diffusion as speciﬁ  ed by the Clinical and Labora-
tory Standards Institute (5). Disks containing ampicillin 
(10 μg), tetracycline (30 μg), trimethoprim (5 μg), nalidixic 
acid (30 μg), chloramphenicol (30 μg), sulfonamide (300 
μg), streptomycin (10 μg), and ciproﬂ  oxacin (5 μg) were 
used for testing on Mueller-Hinton agar (Oxoid, Lenexa, 
Kansas, USA). Of the 18 Nigerian H18 strains, 13 had the 
same resistance pattern: ampicillin, chloramphenicol, strep-
tomycin, sulfonamide, tetracycline, trimethoprim (Table 
1). PCR identiﬁ  ed 3 EAEC-speciﬁ  c and 2 other virulence 
genes (2,6). Markers of well-characterized aggregative ad-
herence plasmids, present in typical EAEC strains, are ag-
gregative adherence regulator gene aggR, anti-aggregative 
protein or dispersin gene aap, and empiric plasmid probe 
(CVD432) that represents part of the aat secretion system 
operon (6). Of the 131 isolates, <30% harbor these loci (7). 
However, 17 (89%) of 18 H18-positive EAEC isolates har-
bored >1 of these aggregative adherence plasmid loci, and 
15 (83%) of 17 harbored all 3 loci (Table 1). Moreover, 15 
(83%) of the 18 isolates contained iucA (aerobactin synthe-
sis), and 17 (94%) contained chuA (heme transport outer-
membrane receptor), signiﬁ  cantly more than the other 113 
EAEC isolates (and 39.8% and 24.8% for iucA and chuA, 
respectively; p<0.001 for each).
Multidrug-resistant, chuA-positive E. coli H18 strains 
are also frequently recovered from patients with urinary 
tract infection. Some of these strains derive from the suc-
cessful and globally disseminated multidrug-resistant clon-
al group A (CGA) (8). Uropathogenic E. coli (UPEC) clon-
al group A strains occur in the United States and Europe; 
typically exhibit serotypes O11:H18, O17:H18, O73:H18, 
or O77:H18; and share a common resistance and repetitive 
element. PCR proﬁ  le (8). Recently, at certain US centers, 
>33% of trimethoprim-resistant E. coli isolates from un-
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complicated cases of pyelonephritis and cystitis have rep-
resented CGA (9). CGA strains also can infect nonurinary, 
extraintestinal sites (10). Furthermore, CGA-like strains 
have been recovered from human and animal feces, which 
implies a commensal reservoir (11,12). Accordingly, we 
assessed our H18 EAEC isolates for membership in CGA.
A CGA-speciﬁ  c PCR protocol, which yields a 175-bp 
PCR product in strains that have 3 single-nucleotide poly-
morphisms within fumC (13), was applied to the Nigerian 
EAEC H18 isolates. Positive controls were 2 reference 
CGA cystitis isolates with UMN026 and SEQ102 (ATCC 
BAA-457) (13); negative controls were non-CGA cystitis 
isolate 2P9 (O15:K52:H1), UPEC isolates CFT073 (O6:
K2:H1) and 536 (O6:K15:H31), and an H18 enterotoxi-
genic E. coli (ETEC) isolate from the Nigeria study (14). 
Of the 18 EAEC H18 isolates, 10 (including 8 from chil-
dren with diarrhea) were positive, whereas 8 (and the H18 
ETEC isolate) were negative. Lack of obvious familial or 
temporal clustering of patients from whom these strains 
were isolated suggests that the isolates are not likely to be 
directly linked through a single point source. Of 21 other 
EAEC strains from diverse non-African locales that were 
similarly screened, including 3 isolates bearing the H18 
ﬂ  iC allele (1), only Thai isolate 144-1 (H18-positive) (1) 
exhibited the CGA-speciﬁ  c fumC single-nucleotide poly-
morphisms. The 2 other non-Nigerian H18 EAEC (Peru-
vian O44:H18 isolate 042 and Thai O36:H18 isolate 44-1) 
(1) were negative.
To unequivocally assess clonal relationships, we sub-
jected all H18 Nigerian EAEC isolates and the Thai isolate 
144-1 to multilocus sequence typing (MLST) (15). Brieﬂ  y, 
we sequenced designated internal regions of the adk, fumC, 
gyrB, icd, mdh, purA, and recA genes. Allele comparisons 
and sequence type (ST) assignments were done by using 
the open-source E. coli MLST database (http://web.mpiib-
berlin.mpg.de/mlst/dbs/Ecoli). All 11 putative EAEC CGA 
isolates carried fumC allele 35, which has all 3 targets of 
the CGA single-nucleotide polymorphism screen (G270A, 
C271T, and C288T) (13). Of these isolates, 10 (9 Nigerian, 
1 Thai) belonged to ST394, which shares 5 of 7 alleles with 
ST69 (the predominant ST of UPEC CGA; [12]) and, ac-
cording to the e-BURST algorithm, is placed with ST69 
Table 1. Properties of H18 EAEC isolates and selected reference strains* 
Strain
Country of 
isolation
Clinical
condition Serotype Motility
CGA
(fumC
SNP) Resistance pattern aggR aap
CVD432
(aat) astA chuA iucA
C08 Nigeria Diarrhea O86:H18  + + Ap St Su Tc Tp  + + + – + +
C14 Nigeria Diarrhea N/K + + Ap Cm St Su Tc Tp  + + + + + +
E23 Nigeria Diarrhea N/K + + Ap Cm St Su Tc Tp  + + + – + +
E30 Nigeria Diarrhea N/K + + Ap Cm St Su Tc Tp  + + + – + +
G10 Nigeria Diarrhea N/K + + Ap Cm St Su Tp  + + + – + +
G17a Nigeria Diarrhea N/K – + Ap Cm St Su Tc Tp  + + + – + +
G59 Nigeria Diarrhea N/K – + Ap Cm St Su Tc Tp  + + + – + +
G67b Nigeria Diarrhea N/K + + Ap Cm St Su Tc Tp  + + + – + +
C16 Nigeria Diarrhea N/K + – Ap Cm St Su Tc Tp  + + + – + –
G55 Nigeria Diarrhea N/K + – Ap Cm St Su Tc Tp  – – – –––
E64 Nigeria Healthy  N/K + + Ap Cm St Su Tc Tp  + + + +++
G108 Nigeria Healthy  N/K + + Ap Cm St Su Tc Tp  – – + +++
E56 Nigeria Healthy  N/K + – Ap Cm St Su Tc  + + + –++
E62 Nigeria Healthy N/K – – Tc + + + –++
E68 Nigeria Healthy  N/K + – Ap Cm St Su Tc Tp  – – + +++
G103 Nigeria Healthy  N/K + – Ap Cm St Su Tc Tp  – – + +++
G121a Nigeria Healthy  N/K + – Ap Cm St Su Tc Tp  + + + –++
G149 Nigeria Healthy  N/K + – Ap St Su Tc Tp  + + + –++
O42 Peru Diarrhea O44:H18  + – Cm St Su Tc Tp  + + + –+–
44-1 Thailand Diarrhea O36:H18  + – Ap Cm St Su Tc  + + + –++
144-1 Thailand Diarrhea O77:NM – + Cm + + + –++
E02   Nigeria Diarrhea Ont:H18  + – Ap Cm St Su Tc Tp  – – – –+–
DH5α† N/A N/A N/A + – – – – – –––
2P9‡ USA UTI O15:K52:H1 N/D – St – – – –++
SEQ102‡  USA  UTI  O11:NT  N/D  +  Ap Cm St Su Tc Tp  –  –  –  –++
UMN026‡ USA  UTI  O17:K52:H18 N/D  +  Ap Cm St  Tc Tp  –  –  –  –++
CFT073‡ USA UTI O6:K2:H1 N/D – – – – – –++
*EAEC, enteroaggregative Escherichia coli; CGA, clonal group A; SNP, single nucleotide polymorphism; Ap, ampicillin; St, streptomycin; Su, sulfonamide; 
Tc, tetracycline; Tp, trimethoprim; N/K, not known; Cm, chloramphenicol; N/A, not applicable; UTI, urinary tract infection; N/D, not determined. All strains 
were susceptible to nalidixic acid and ciprofloxacin.  All pathotypes are EAEC (H18) unless otherwise noted. 
†Pathotype K-12.
‡Pathotype uropathogenic E. coli.Enteroaggregative E. coli Related to Clonal Group A
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in the same larger ST69 complex, indicative of a recent 
common ancestor (15). One Nigerian H18 EAEC isolate, 
strain E23, was assigned a new ST, ST432, because of 
its novel purA allele; however, ST432 shares alleles with 
ST394 at all 6 other loci and so also belongs with the ST69 
complex. Of the 8 H18 isolates that were negative in the 
fumC35 single-nucleotide polymorphism assay, 7 belonged 
to STs not previously described. Only 1 of these, strain E62 
(ST471), shared 6 alleles with ST394 and 4 with ST69. 
Another strain, C16 (ST512), shared 5 alleles with ST69 
and only 4 with ST394. Of the 8 fumC35-negative H18 iso-
lates, 6 did not share 5 alleles with ST69 or ST394 and are 
therefore considered to be of a different clonal complex. 
Six fumC35-negative H18 isolates had 6 alleles in common 
and belonged to 1 of 3 STs: 31, 449, or 474. ST31 includes 
other EAEC in the MLST database (www.mlst.net). One 
EAEC H18 isolate shared no allele with any other EAEC 
isolate from this study (Table 2).
Although iron-utilization genes chuA and iucA are 
present in all EAEC and UPEC ST69 complex strains, the 
EAEC virulence plasmid markers aggR, aap, and CVD432 
(aat) were found in all 11 EAEC ST394/432 isolates but not 
in reference UPEC CGA (ST69) isolates (Table 1). EAEC 
ST394/432 strains and UPEC ST69 (CGA) strains appear 
to represent diverging lineages of common ancestry, which 
are adapting to separate niches. Escobar-Paramo (14) pro-
posed that certain E. coli backgrounds appear to be more 
likely to acquire virulence genes. Our ﬁ  ndings suggest that 
the ST69 complex progenitor, from which CGA UPEC and 
ST394 EAEC are derived, may have had a propensity to 
acquire virulence genes as well as antimicrobial resistance 
elements, thereby generating at least 2 clonal groups patho-
genic for humans, with several nonoverlapping, horizon-
tally acquired virulence factors.
CGA-like strains recently isolated from animal feces 
and food samples have been proposed by Ramchandani et 
al. (11) as possible reservoirs for UPEC CGA strains. How-
ever, although they found similar resistance patterns and 
serotypes among animal CGA isolates as among humans, 
they did not ﬁ  nd typical UPEC-associated virulence gene 
proﬁ  les (11). Tartof et al. (12) have subsequently shown 
that CGA-like strains from animal or environmental sourc-
es do not belong to ST69 (as do most human UPEC CGA 
isolates) but that they are part of the ST69 complex, par-
ticularly the ST394 type, which corresponds to the EAEC 
H18 clonal group we describe. Nonhuman ST394 isolates 
could possibly represent CGA-like EAEC and point to po-
tential nonhuman reservoirs of EAEC, which remain to be 
identiﬁ  ed.
Conclusions
ST69 and ST394 appear to represent successful, ge-
netically related lineages; isolates belonging to both are 
commonly resistant to ampicillin, chloramphenicol, strep-
tomycin, sulfonamides, tetracycline, and trimethoprim. 
Widespread use of trimethoprim-sulfamethoxazole has 
been proposed as a reason for the emergence and spread of 
UPEC CGA (8). This combination, as well as other drugs 
to which ST394 strains are typically resistant, is com-
monly used (and misused) in Nigeria and other developing 
Table 2. Multilocus sequence types of CGA-associated fumC single-nucleotide polymorphism–positive strains* 
Allele profile 
Strain
Clinical condition, 
country  adk fumC gyrB icd mdh purA recA ST ST complex 
C08 Diarrhea, Nigeria  21 35 61 52 5 5 4 394 69
C14 Diarrhea, Nigeria  21 35 61 52 5 5 4 394 69
E23 Diarrhea, Nigeria  21 35 61 52 5 72 4 432 69
E30 Diarrhea, Nigeria  21 35 61 52 5 5 4 394 69
G10 Diarrhea, Nigeria  21 35 61 52 5 5 4 394 69
G17a Diarrhea, Nigeria  21 35 61 52 5 5 4 394 69
G59 Diarrhea, Nigeria  21 35 61 52 5 5 4 394 69
G67b Diarrhea, Nigeria  21 35 61 52 5 5 4 394 69
E64 Healthy, Nigeria  21 35 61 52 5 5 4 394 69
G108 Healthy, Nigeria  21 35 61 52 5 5 4 394 69
144-1 Diarrhea, Thailand  21 35 61 52 5 5 4 394 69
SEQ102† UTI (CGA), USA  21 35 27 6 5 5 4 69 69
C16 Healthy, Nigeria  21 22 2 6 5 5 4 512 Unassigned
G55 Healthy, Nigeria  6 4 33 1 20 12 7 423 Unassigned
E56 Healthy, Nigeria  18 22 17 6 5 5 4 31 31
E62 Healthy, Nigeria  21 125 61 52 5 5 4 471 Unassigned
E68 Healthy, Nigeria  18 22 94 6 5 5 4 449 Unassigned
G103 Healthy, Nigeria  18 22 94 6 5 5 4 449 Unassigned
G121a Healthy, Nigeria  18 22 1 6 5 5 4 474 Unassigned
G149 Healthy, Nigeria  18 22 1 6 5 5 4 474 Unassigned
*CGA, clonal group A; ST, sequence type; UTI, urinary tract infection. 
†Data from reference (14). Data for all other isolates are from this study. DISPATCHES
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countries and could provide selective pressure for EAEC 
ST394/432. Although our numbers were too small to sig-
niﬁ  cantly associate ST394/432 strains with disease, 8 of 
10 of these isolates were from children with diarrhea. Our 
study has unveiled what we believe to be a previously un-
recognized EAEC clonal group. The fumC single-nucleo-
tide polymorphism method, proposed for identifying UPEC 
CGA, could be useful for assessing its distribution.
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